Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study

Pinto, C.;Di Fabio, F.;Rosati, G.;Lolli, I. R.;Ruggeri, E. M.;Ciuffreda, L.;Ferrari, D.;Lo Re, G.;Rosti, G.;Tralongo, P.;Ferrara, R.;Alabiso, O.;Chiara, S.;Ianniello, G. P.;Frassoldati, A.;Bilancia, D.;Campanella, G. A.;Signorelli, C.;Racca, P.;Benincasa, E.;Stroppolo, M. E.;Di Costanzo, F.

2016-01-01